Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
O’Day Lays Out Plan For Gilead’s Continued HIV Dominance
Jan 14 2020
•
By
Joseph Haas
In San Francisco, Gilead CEO O'Day detailed how the company will maintain its dominance in HIV
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Strategy
More from Business